Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy

To determine whether pretreatment 3T multiparametric MRI (mpMRI) staging impacts biochemical recurrence-free survival (BRFS) or distant metastasis-free survival (DMFS) for men with high-risk prostate cancer treated with combination high-dose-rate (HDR) brachytherapy and external beam radiation therapy (EBRT).

Source: Brachytherapy - August 11, 2017 Category: Cancer & Oncology Authors: John V. Hegde, D. Jeffrey Demanes, Darlene Veruttipong, Jagdeep Raince, Sang-June Park, Steven S. Raman, Nicholas G. Nickols, Christopher R. King, Amar U. Kishan, Michael L. Steinberg, Mitchell Kamrava Source Type: research